Clinical trial NCT02435589: The Effects of a Systematic Pain Assessment Approach on Critically Ill Patients Outcomes in ICU
Official title: The Effects of a Systematic Pain Assessment Approach on Critically Ill Patients Outcomes: A Randomized Interventional Clinical Study
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Pain
Lead sponsor: Cyprus University of Technology
Sponsor class: OTHER
Collaborators: name: Nicosia General Hospital
First posted: 2015-05-06
Enrollment: 120
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: The purpose of this study is to investigate the effectiveness of a systematic approach to pain assessment in the critically ill patients' outcome The investigators hypothesize that, patients who will undergo systematic pain assessment and they will have their results notified to physicians and nurses, will demonstrate favorable effects on pain intensity, more efficient use of sedatives and analgesics, duration of mechanical ventilation, length of ICU stay, mortality, adverse events and complications, in relation to patients who will receive standard care alone. Moreover it is expected that they will demonstrate altered levels of plasma neuropeptides and biochemical markers in peripheral blood.

Detailed description: Appropriate pain management depends on the systematic and comprehensive assessment of pain. Inaccurate pain assessment and the resulting inadequate treatment of pain in critically ill adults can have significant physiological and psychological consequences.

The investigators will examine whether a systematic pain assessment approach can improve patients outcomes.

120 ICU patients will be randomized either to control or intervention group. The control group will receive standard care plus pain assessments but nurses and physicians will be blind of these results. The intervention group will receive standard care plus systematic pain assessment and the results will be notified to nurses and physicians.

Eligibility criteria: Inclusion Criteria:

* 18 years and older
* All patients with an estimated source of pain or due to immunological process as trauma, surgery, or due to general factors such as endotracheal intubation, interventional catheters

Exclusion Criteria:

* Length of stay in the ICU \<24 hours
* The patient receives neuromuscular blockers,
* The patient has a disease or condition, such as Guillain-Barre, peripheral neuropathy, which modifies sensory transmission of painful stimuli
* The patient has a disease or condition which complicates the assessment of pain behavior, such as decerebration or vegetative state, agitation\> 3 in the Richmond Agitation sedation Scale (RASS)

Primary outcomes:
measure: a) Level of pain (intensity, incidence of high levels of pain with a numerical pain scale NRS> 6, Behavioral pain scale (BPS) > 5 and Critical pain observation Tool (C-POT) >2
timeFrame: morning between 9:00-11: hrs, and afternoon between 4:00-6:00 hrs) for ten continuous days
measure: To investigate the effect of the systematic assessment of pain among patients groups - control and intervention as to:The total dose, frequency of administration and the type of analgesics and sedatives received
timeFrame: every 24 hrs for ten continuous days
Secondary outcomes:
measure: Effect of the systematic evaluation of pain among patients groups - control and intervention as to:The degree of sedation/agitation
timeFrame: morning between 9:00-11: hrs, and afternoon between 4:00-6:00 hrs) for ten continuous days
measure: Effect of the systematic evaluation of pain among patients groups - control and intervention as to:The levels of biochemical marker, cortisol, in the serum
timeFrame: morning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample)
measure: Effect of the systematic evaluation of pain among patients groups - control and intervention as to:The levels of biochemical marker corticotrophin hormone -ACTH in the serum
timeFrame: morning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample)
measure: Effect of the systematic evaluation of pain among patients groups - control and intervention as to: The levels of biochemical marker, b-endorphin in the serum
timeFrame: morning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample)
measure: Effect of the systematic evaluation of pain among patients groups - control and intervention as to: The levels of neuropeptide Y
timeFrame: morning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample)
measure: Effect of the systematic evaluation of pain among patients groups - control and intervention as to: The levels of neuropeptide , substance P in the serum
timeFrame: morning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample)
measure: To investigate the effect of the systematic assessment of pain among patients groups - control and intervention as to duration of mechanical ventilation
timeFrame: Day and time of initiation of mechanical ventilation till the day and time of end of mechanical ventilation, up to six months.
measure: To investigate the effect of the systematic assessment of pain among patients groups - control and intervention as to length of stay in the ICU
timeFrame: From the day of admission to ICU till the day of discharge from ICU, up to six months
measure: To investigate the effect of the systematic assessment of pain among patients groups - control and intervention as to the occurrence of adverse events
timeFrame: every 24 hrs for ten continuous days
Other outcomes:
Locations:
city: Nicosia
country: Cyprus
facility: Nicosia General Hospital
Study officials:
affiliation: Cyprus University of Technology
name: Evanthia G Georgiou, PhD Cand
role: PRINCIPAL_INVESTIGATOR
References: